CAR-T Therapy Clinical Trials Reveal High Inflammation Rates but Low Mortality
A meta-analysis of twenty-one clinical trials reveals that CAR-T cell therapy carries a 77.6 percent cytokine release syndrome incidence but ...
A meta-analysis of twenty-one clinical trials reveals that CAR-T cell therapy carries a 77.6 percent cytokine release syndrome incidence but ...
A national panel of Saudi hematologists has outlined clinical eligibility criteria and health system frameworks to expand adult access to ...
A retrospective cohort study reveals that while half of CAR T-cell recipients met European cardio-oncology toxicity criteria, the classification was ...
An early study of 28 Korean DLBCL patients found that positive Deauville 4–5 findings on post-CAR T-cell PET/CT scans were ...
Chimeric antigen receptor (CAR) T cell therapy has emerged as a revolutionary approach in the treatment of hematologic malignancies, particularly ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.